131 related articles for article (PubMed ID: 29152118)
1. Sensitization of neuroblastoma for vincristine-induced apoptosis by Smac mimetic LCL161 is attended by G2 cell cycle arrest but is independent of NFκB, RIP1 and TNF-α.
Langemann D; Trochimiuk M; Appl B; Hundsdoerfer P; Reinshagen K; Eschenburg G
Oncotarget; 2017 Oct; 8(50):87763-87772. PubMed ID: 29152118
[TBL] [Abstract][Full Text] [Related]
2. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.
Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S
Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016
[TBL] [Abstract][Full Text] [Related]
3. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
[TBL] [Abstract][Full Text] [Related]
4. Vincristine resistance in relapsed neuroblastoma can be efficiently overcome by Smac mimetic LCL161 treatment.
Frommann K; Appl B; Hundsdoerfer P; Reinshagen K; Eschenburg G
J Pediatr Surg; 2018 Oct; 53(10):2059-2064. PubMed ID: 29455885
[TBL] [Abstract][Full Text] [Related]
5. LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling.
Afsahi A; Silvestri CM; Moore AE; Graham CF; Bacchiochi K; St-Jean M; Baker CL; Korneluk RG; Beug ST; LaCasse EC; Bramson JL
Front Immunol; 2023; 14():1179827. PubMed ID: 37138866
[TBL] [Abstract][Full Text] [Related]
6. RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex.
Abhari BA; Cristofanon S; Kappler R; von Schweinitz D; Humphreys R; Fulda S
Oncogene; 2013 Jul; 32(27):3263-73. PubMed ID: 22890322
[TBL] [Abstract][Full Text] [Related]
7. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
8. Smac mimetic LCL161 supports neuroblastoma chemotherapy in a drug class-dependent manner and synergistically interacts with ALK inhibitor TAE684 in cells with ALK mutation F1174L.
Najem S; Langemann D; Appl B; Trochimiuk M; Hundsdoerfer P; Reinshagen K; Eschenburg G
Oncotarget; 2016 Nov; 7(45):72634-72653. PubMed ID: 27655666
[TBL] [Abstract][Full Text] [Related]
9. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.
Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S
Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979
[TBL] [Abstract][Full Text] [Related]
10. Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitro.
Scheurer MJJ; Seher A; Steinacker V; Linz C; Hartmann S; Kübler AC; Müller-Richter UDA; Brands RC
J Craniomaxillofac Surg; 2019 Oct; 47(10):1589-1599. PubMed ID: 31387829
[TBL] [Abstract][Full Text] [Related]
11. OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3.
Zhang B; Yang C; Wang R; Wu J; Zhang Y; Liu D; Sun X; Li X; Ren H; Qin S
J Exp Clin Cancer Res; 2020 Nov; 39(1):244. PubMed ID: 33198776
[TBL] [Abstract][Full Text] [Related]
12. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
Chromik J; Safferthal C; Serve H; Fulda S
Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
[TBL] [Abstract][Full Text] [Related]
13. Smac mimetic LBW242 sensitizes XIAP-overexpressing neuroblastoma cells for TNF-α-independent apoptosis.
Eschenburg G; Eggert A; Schramm A; Lode HN; Hundsdoerfer P
Cancer Res; 2012 May; 72(10):2645-56. PubMed ID: 22491673
[TBL] [Abstract][Full Text] [Related]
14. Induction of Necroptosis in Human Breast Cancer Drug-Resistant Cells by SMAC Analog LCL161 After Caspase Inhibition Requires RIP3.
Jin G; Liu Y; Xu P; Jin G
Pharmazie; 2019 Jun; 74(6):363-368. PubMed ID: 31138375
[TBL] [Abstract][Full Text] [Related]
15. Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells.
Gerges S; Rohde K; Fulda S
Cancer Lett; 2016 May; 375(1):127-132. PubMed ID: 26944210
[TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase 1 inhibition sensitizes neuroblastoma cells for vinca alkaloid-induced apoptosis.
Czaplinski S; Hugle M; Stiehl V; Fulda S
Oncotarget; 2016 Feb; 7(8):8700-11. PubMed ID: 26046302
[TBL] [Abstract][Full Text] [Related]
17. Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y human neuroblastoma cells.
Tu Y; Cheng S; Zhang S; Sun H; Xu Z
Int J Mol Med; 2013 Jan; 31(1):113-9. PubMed ID: 23129065
[TBL] [Abstract][Full Text] [Related]
18. PKC activation sensitizes basal-like breast cancer cell lines to Smac mimetics.
Cornmark L; Holmgren C; Masoumi K; Larsson C
Cell Death Discov; 2016; 2():16002. PubMed ID: 27551497
[TBL] [Abstract][Full Text] [Related]
19. Smac mimetic sensitizes renal cell carcinoma cells to interferon-α-induced apoptosis.
Reiter M; Eckhardt I; Haferkamp A; Fulda S
Cancer Lett; 2016 May; 375(1):1-8. PubMed ID: 26912071
[TBL] [Abstract][Full Text] [Related]
20. SMAC exhibits anti-tumor effects in ECA109 cells by regulating expression of inhibitor of apoptosis protein family.
Jiang N; Zhang WQ; Dong H; Hao YT; Zhang LM; Shan L; Yang XD; Peng CL
World J Clin Cases; 2021 Jul; 9(19):5019-5027. PubMed ID: 34307552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
